ACR 2022 Tweet by TheDaoIndex
Tweet
Related Content
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.17 Sept EMA CHMP recommended marketing authorisation for secukinumab (Cosentyx) in the treatment of polymyalgia rheumatica. BUT- not yet EMA approved in the EU. https://t.co/ZGUSbw06vXNew report shows Median…
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com4,197 pts from the UK Biobank met fibromyalgia criteria, yet 72.6% had NOT received a diagnosis. Non-Dx assoc w/ male, older age, milder sxs or other pain Dx (OA, CRPS, CFS), lower polysymptomatic distress scores,…
Podcast
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, calcinosis, CTD skin disorders. dermatology drugs, biologics, and JAK inhibitors.
Features Dr. Jack Cush, Editor at RheumNow.com.
Show Notes:
FDA Grants Priority…
